Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am Eastern Time.
Conference Call and Webcast Information
|
Event |
Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call |
|
Date |
Thursday, August 15, 2024 |
|
Time |
10:00am ET |
|
Conference Call |
1-877-877-1275 (U.S.) 1-412-858-5202 (international) |
|
Webcast |
https://event.choruscall.com/mediaframe/webcast.html?webcastid=bU2HFqrt |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts:
Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
View the original press release on accesswire.com
